Company Name: XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd. is a biopharmaceutical company. The company is focused on the development of treatments for autoimmune diseases. The company’s lead product candidate is a treatment for systemic lupus erythematosus (SLE).
Ticker Symbol: XTLB (NASDAQ)
Company Website: www.xtlbio.com
Social Media: XTL Biopharmaceuticals LinkedIn
Headquarters: Raanana, Israel